Work

Combining CD3 density and PD-L1 expression into one prognostic factor identifies patients with an exceptional prognosis

Year: 2024

Type: article

Study design: Observational Study

Source: Laryngo-Rhino-Otologie

DOI: 10.1055/s-0044-1784752

Authors: Simon Laban, Romain Remark, Christian Idel, Julika Ribbat-Idel, Rosemarie Krupar, Andreas Schröck, Niklas Klümper, Johannes Döscher, Andrew G. Sikora, Tsima Abou Kors, Adrian von Witzleben, Julius Vahl, Ayla Grages, Michael Sonntag, Cornelia Brunner, Thomas Hoffmann, Sven Perner, Sacha Gnjatic

Institutions: University Hospital Ulm, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, University Hospital Schleswig-Holstein, University Hospital Bonn, University Hospital Augsburg, The University of Texas MD Anderson Cancer Center, Institut für Hämatopathologie Hamburg

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4395049786

FWCI:

Cites:

Cited by:

Related to: 10